Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisomal biogenesis factor 39 (PEX39) is a cytosolic peroxisomal biogenesis protein (peroxin) that facilitates the import of proteins containing a type 2 peroxisomal targeting signal (PTS2) by binding and stabilizing PEX7, the carrier for these cargo proteins. PEX39 carries a KPWE motif crucial for PEX7 interaction and operates alongside PEX13 to coordinate the sequential movement of cargo into the peroxisome. Proper levels of PEX39 are necessary for efficient protein import: both depletion and overexpression disrupt peroxisomal protein import and maturation. PEX39 dysfunction can cause severe peroxisomal disorders such as Zellweger Spectrum Disorders, and its discovery fills a longstanding gap in the molecular understanding of human peroxisome assembly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal biogenesis factor 39 (PEX39).